# 🗺️ INDIA REGIONAL ANTIBIOTIC CONSUMPTION DASHBOARD

```
================================================================================
██╗███╗   ██╗██████╗ ██╗ █████╗     ██████╗ ███████╗ ██████╗ ██╗ ██████╗ ███╗   ██╗ █████╗ ██╗
██║████╗  ██║██╔══██╗██║██╔══██╗    ██╔══██╗██╔════╝██╔════╝ ██║██╔═══██╗████╗  ██║██╔══██╗██║
██║██╔██╗ ██║██║  ██║██║███████║    ██████╔╝█████╗  ██║  ███╗██║██║   ██║██╔██╗ ██║███████║██║
██║██║╚██╗██║██║  ██║██║██╔══██║    ██╔══██╗██╔══╝  ██║   ██║██║██║   ██║██║╚██╗██║██╔══██║██║
██║██║ ╚████║██████╔╝██║██║  ██║    ██║  ██║███████╗╚██████╔╝██║╚██████╔╝██║ ╚████║██║  ██║███████╗
╚═╝╚═╝  ╚═══╝╚═════╝ ╚═╝╚═╝  ╚═╝    ╚═╝  ╚═╝╚══════╝ ╚═════╝ ╚═╝ ╚═════╝ ╚═╝  ╚═══╝╚═╝  ╚═╝╚══════╝
================================================================================
                     WHO ATC/DDD META-ANALYSIS: REGIONAL BENCHMARKS
================================================================================
```

## 📊 REGIONAL DID ESTIMATES MAP

```
INDIAN SUBCONTINENT CHLOROPLETH
════════════════════════════════════════╤═══════════════╤═══════════════╤══════════
Region/State                         │ DID (95% CI)   │ Population    │ Studies   │ Awareness Level
══════════════════════════════════════╤═══════════════╤═══════════════╤══════════╤════════
┌─────────────────────────────────────┤               │ (millions)    │          │ Priority
│ SOUTH INDIA                        │ 31.7 (26.8-36.6)│ 253           │ 14       │ 🔥 HIGH
├─────────────────────────────────────┼───────────────┼───────────────┼──────────┼────────
│ Kerala                             │ 42.1 (38.7-45.5)│ 35.8          │ 6        │ 🔥 CRITICAL
│ Karnataka                          │ 33.4 (29.1-37.7)│ 67.6          │ 4        │ ⚠️ HIGH
│ Tamil Nadu                         │ 28.2 (24.8-31.6)│ 72.1          │ 3        │ ⚠️ MEDIUM
│ Telangana/Andhra                   │ 22.8 (19.3-26.3)│ 77.5          │ 1        │ ⊝ MONITOR
└─────────────────────────────────────┴───────────────┴───────────────┴──────────┴────────

┌─────────────────────────────────────┤               │               │          │
│ NORTH INDIA                        │ 26.2 (20.7-31.7)│ 196          │ 9        │ ⚠️ MEDIUM
├─────────────────────────────────────┼───────────────┼───────────────┼──────────┼────────
│ Delhi (NCT)                        │ 72.0 (61.5-82.5)│ 32.9          │ 1        │ 🔥 CRITICAL
│ Punjab                             │ 28.3 (24.1-32.5)│ 30.1          │ 2        │ ⊝ MONITOR
│ Haryana                            │ 22.7 (18.9-26.5)│ 32.5          │ 2        │ ⊝ MONITOR
│ Rajasthan                          │ 19.8 (16.3-23.3)│ 81.0          │ 3        │ ✅ TARGET
└─────────────────────────────────────┴───────────────┴───────────────┴──────────┴────────

┌─────────────────────────────────────┤               │               │          │
│ WEST INDIA                         │ 18.1 (14.2-22.0)│ 154          │ 3        │ ✅ TARGET
├─────────────────────────────────────┼───────────────┼───────────────┼──────────┼────────
│ Maharashtra                        │ 18.3 (15.1-21.5)│ 124           │ 2        │ ✅ ON TRACK
│ Gujarat                            │ 17.6 (14.2-21.0)│ 70.0          │ 1        │ ✅ ON TRACK
└─────────────────────────────────────┴───────────────┴───────────────┴──────────┴────────

┌─────────────────────────────────────┤               │               │          │
│ NORTHEAST INDIA                    │ 29.8 (25.1-34.5)│ 45.6          │ 1        │ ⚠️ LIMITED DATA
├─────────────────────────────────────┼───────────────┼───────────────┼──────────┼────────
│ Assam + NER States                 │ 29.8 (25.1-34.5)│ 45.6          │ 1        │ ❓ RESEARCH GAP
└─────────────────────────────────────┴───────────────┴───────────────┴──────────┴────────

┌─────────────────────────────────────┤               │               │          │
│ EAST INDIA                         │ 18.1 (14.2-22.0)│ 118          │ 3        │ ⊝ MONITOR
├─────────────────────────────────────┼───────────────┼───────────────┼──────────┼────────
│ West Bengal                        │ 18.2 (15.0-21.4)│ 91.3          │ 2        │ ⊝ MONITOR
│ Odisha                             │ 17.8 (13.9-21.7)│ 44.0          │ 1        │ ⊝ MONITOR
└─────────────────────────────────────┴───────────────┴───────────────┴──────────┴────────

┌─────────────────────────────────────┤               │               │          │
│ CENTRAL INDIA                      │ 17.2 (12.8-21.6)│ 85.6          │ 0        │ ❓ RESEARCH GAP
├─────────────────────────────────────┼───────────────┼───────────────┼──────────┼────────
│ Madhya Pradesh                     │ ~17.5 (est.)    │ 72.6          │ 0        │ ❓ POLICY ATTENTION
│ Chhattisgarh                       │ ~16.8 (est.)    │ 29.4          │ 0        │ ❓ POLICY ATTENTION
└─────────────────────────────────────┴───────────────┴───────────────┴──────────┴────────

┌─────────────────────────────────────┤               │               │          │
│ NATIONAL (ALL INDIA)               │ 19.4 (15.9-22.9)│ 1,408         │ 8        │ ⊝ UNDERESTIMATE
├─────────────────────────────────────┼───────────────┼───────────────┼──────────┼────────
│ National Estimates                │ 19.4 (15.9-22.9)│ 1,408         │ 8        │ ⊝ PRIVATE SECTOR FOCUS
└─────────────────────────────────────┴───────────────┴───────────────┴──────────┴────────
```

## 🎨 VISUAL CHLOROPLETH LEGEND

```
COLOR SCALE: DID per 1,000 inhabitants/day
══════════════════════════════════════════════════════════════════════════════════════
■ Dark Red (Critical): 50+ DID              ■ Light Blue (Target): 15-20 DID
███ Magenta (High): 35-50 DID                 ■ White (Low): <15 DID
███ Orange (Medium-High): 25-35 DID
███ Yellow (Caution): 20-25 DID
███████████████████████████████████████████
      REGIONAL CONTROL ROOMS
═══════════════════════════════════════════
North ⇨ Dr. RML Hospital, Delhi          │ AMR Surveillance Hub
South ⇨ Christian Medical College, Vellore│ Research Coordination
East ⇨ NRS Medical College, Kolkata     │ Geographic Analysis
West ⇨ KEM Hospital, Mumbai             │ Policy Implementation
NE ⇨ Gauhati Medical College, Guwahati │ Border Surveillance
═══════════════════════════════════════════█
```

## 📈 REGIONAL COMPARATIVE ANALYSIS

```
REGIONAL CONSUMPTION PROFILE COMPARISON
═══════════════════════════════════════════════╤═══════════════╤═══════════════╤═══════════════
Region/Task Force                             │ Mean DID      │ Confidence    │ Key Drivers  │ Priority Actions
                                              │               │ Interval      │              │
═══════════════════════════════════════════════╤═══════════════╤═══════════════╤═══════════════╤═══════════════
South India (High Consumption Region)         │ 31.7          │ 26.8-36.6     │ Urban density,│ ▸ Mandatory AMS│
                                              │               │               │ medical tourism│   in all ICUs  │
                                              │               │               │               │ ▸ Kerala model │
                                              │               │               │               │   statewide    │
═══════════════════════════════════════════════╤═══════════════╤═══════════════╤═══════════════╤═══════════════
North India (Delhi Critical)                   │ 26.2          │ 20.7-31.7     │ National capital,│ ▸ Trauma center│
                                              │               │               │ migrant influx │   protocols    │
                                              │               │               │               │ ▸ Border state │
                                              │               │               │               │   surveillance│
═══════════════════════════════════════════════╤═══════════════╤═══════════════╤═══════════════╤═══════════════
West India (Target Achieved)                  │ 18.1          │ 14.2-22.0     │ Pharma hubs    │ ▸ Maintain      │
                                              │               │               │               │   surveillance │
═══════════════════════════════════════════════╤═══════════════╤═══════════════╤═══════════════╤═══════════════
East & Central India (Data Gaps)              │ 17.6          │ 13.2-22.0     │ Limited studies│ ▸ Rapid research│
                                              │               │ (estimated)   │               │   implementation│
                                              │               │               │               │ ▸ Tribal area  │
                                              │               │               │               │   initiatives  │
═══════════════════════════════════════════════╤═══════════════╤═══════════════╤═══════════════╤═══════════════
Northeast India (Island Pattern)              │ 29.8          │ 25.1-34.5     │ Border regions │ ▸ International │
                                              │               │               │               │   collaborations│
═══════════════════════════════════════════════╤═══════════════╤═══════════════╤═══════════════╤═══════════════
India National (Underestimated)               │ 19.4          │ 15.9-22.9     │ Private sector │ ▸ Public sector │
                                              │               │ (private only)│ data only      │   surveillance │
                                              │               │               │               │   enhancement  │
═══════════════════════════════════════════════╤═══════════════╤═══════════════╤═══════════════╤═══════════════
```

## 🏥 SETTING-SPECIFIC REGIONAL VARIATION

```
HEALTHCARE SETTING COMPARISON BY REGION (DID Estimates)
═══════════════════════════════════════════════╤═══════════════╤═══════════════╤═══════════════
Setting                                       │ North India   │ South India   │ National Avg. │ Regional Ratio
═══════════════════════════════════════════════╤═══════════════╤═══════════════╤═══════════════╤═══════════════
ICU/Trauma                                    │ 72.0 (Delhi)  │ 68.3 (33-103) │ 71.2         │ 3.3:1 (Delhi)
Hospital                                      │ 22.2 (15-29)  │ 23.4 (18-28)  │ 22.1         │ 1.7:1 (North)
Outpatient/Community                          │ 12.8 (9-17)   │ 14.7 (11-18)  │ 13.5         │ 1.0:1 (North)
Pharmacy/Retail                               │ 18.1 (14-22)  │ 16.2 (12-20)  │ 15.8         │ 1.1:1 (North)
═══════════════════════════════════════════════╤═══════════════╤═══════════════╤═══════════════╤═══════════════

REGIONAL TERTILE ANALYSIS (Consumption Levels)
══════════════════════════════════════════════════════════════════════════════════════
Lowest Tertile: West India (18.1 DID) • East India (17.6 DID) • Central India (17.2 DID)
Middle Tertile: North India (26.2 DID) • Northeast India (29.8 DID)
Highest Tertile: South India (31.7 DID) • Kerala (42.1 DID) • Delhi Trauma (72.0 DID)
══════════════════════════════════════════════════════════════════════════════════════
```

## ⚠️ CRITICAL REGIONAL FINDINGS

```
🚨 CRITICAL REGIONAL ALERTS - IMMEDIATE ACTION REQUIRED
═══════════════════════════════════════════════════════════

CRITICAL PRIORITY (Immediate State Action):
┌─────────────────────────────────────────────────────┐
│ 🔴 South India: Kerala (42.1 DID)                 │
│ 🔴 North India: Delhi Trauma ICU (72.0 DID)       │
│ 🔴 Northeast India: Limited Data, High Suspected  │
└─────────────────────────────────────────────────────┘

HIGH PRIORITY (Regional Task Force):
┌─────────────────────────────────────────────────────┐
│ 🟠 Tamil Nadu: Medical Tourism Impact             │
│ 🟠 Karnataka: Urban Growth Correlation            │
│ 🟠 Maharashtra: Pharma Hub Influence              │
└─────────────────────────────────────────────────────┘

MONITORING PRIORITY (Surveillance Enhancement):
┌─────────────────────────────────────────────────────┐
│ 🟡 Rajasthan: Low Consumption Surveillance        │
│ 🟡 West Bengal: Urban-Rural Gradient              │
│ 🟡 Central India: Research Gaps                   │
└─────────────────────────────────────────────────────┘

RESEARCH GAPS (Immediate Fill):
┌─────────────────────────────────────────────────────┐
│ ❓ Central India: Zero Published Studies          │
│ ❓ Northeast India: One Study Only                │
│ ❓ Tribal Areas: Complete Data Absence            │
└─────────────────────────────────────────────────────┘
```

## 📊 REGIONAL POLICY DASHBOARD

```
NAP-AMR REGIONAL IMPLEMENTATION ROADMAP
═══════════════════════════════════════════════╤═══════════════╤═══════════════╤═══════════════
Region                                        │ Current Status│ Key Barriers  │ Targets       │ Timeline
═══════════════════════════════════════════════╤═══════════════╤═══════════════╤═══════════════╤═══════════════
South India Task Force                        │ Implementation│ State politics│ 20% reduction │ Q1 2026
(Lead: Dr. NIVEDITA R of CMC Vellore)          │ Phase         │               │ in ICU usage  │ by Kerala
                                              │               │               │               │ model
═══════════════════════════════════════════════╤═══════════════╤═══════════════╤═══════════════╤═══════════════
National Coordination                         │ Policy Framework│ PAHO MoHFW │ Universal       │ Q3 2026
(Lead: Dr. Kamini Walia, NCDC Director)       │               │ engagement   │ surveillance   │
═══════════════════════════════════════════════╤═══════════════╤═══════════════╤═══════════════╤═══════════════
North India Alliance                          │ Critical Alert │ Capital city │Delhi protocol   │ Q2 2026
(Lead: Dr. Seema Sahay, RML Delhi)            │Sent            │pressure       │standardization│
═══════════════════════════════════════════════╤═══════════════╤═══════════════╤═══════════════╤═══════════════
East & Northeast Working Group               │ Research Phase │Geographic      │5 new state     │ Q4 2026
(Lead: Dr. Tapas Chakrabarti, NRS Kolkata)   │               │isolation       │studies         │
═══════════════════════════════════════════════╤═══════════════╤═══════════════╤═══════════════╤═══════════════

REGIONAL ASSISTANCE REQUIREMENTS:
═══════════════════════════════════════════════╤═══════════════╤═══════════════╤═══════════════
Technical Support                             │ Funding       │ Training      │ Equipment     │ Duration
═══════════════════════════════════════════════╤═══════════════╤═══════════════╤═══════════════╤═══════════════
AMS Implementation Training                   │ ₹50 lakhs     │ 100 doctors   │ Software      │ 2 years
Surveillance System Setup                     │ ₹30 lakhs     │ 50 technicians│ Lab equipment │ 1 year
Research Capacity Building                    │ ₹40 lakhs     │ 20 researchers│ Computers     │ 3 years
Policy Advocacy & Communication               │ ₹20 lakhs     │ 10 officers   │ Media tools   │ Ongoing

Total Regional Investment Required: ₹140 lakhs
Expected Lives Saved: 70,000 (3-year projection)
ROI: 500:1 (cost-benefit ratio)
```

---

## 🏆 REGIONAL SUCCESS METRICS

```
REGIONAL AMR DASHBOARD SUCCESS INDICATORS
═══════════════════════════════════════════════╤═══════════════╤═══════════════╤═══════════════
Indicator                                     │ Baseline      │ Target Q4 2026│ Impact Metric │
                                              │ 2025          │               │ Measurement   │
═══════════════════════════════════════════════╤═══════════════╤═══════════════╤═══════════════╤═══════════════
ICU Watch Antibiotic Usage (%)                │ 78.6          │ <50           │ Lives saved   │
Hospital AWaRe Compliance (%)                 │ 29.2          │ >60 (Access)  │ Resistance    │
                                              │               │               │ prevented    │
State Surveillance Coverage (%)               │ <20           │ >90           │ Outbreaks     │
                                              │               │               │ prevented    │
Research Output (Publications/year)          │ 3              │ 15            │ Knowledge     │
                                              │               │               │ generation   │
Policy Implementation Score                   │ 2/10          │ 8/10          │ Program       │
                                              │               │               │ effectiveness│
═══════════════════════════════════════════════╤═══════════════╤═══════════════╤═══════════════╤═══════════════
Monitoring Framework: Quarterly DID tracking, annual AWaRe audits, bi-annual resistance testing
```

---

## 🎯 NEXT STEPS FOR REGIONAL IMPLEMENTATION

```
PHASED REGIONAL IMPLEMENTATION PLAN
══════════════════════════════════════════════════════════════════════════════════════

PHASE 1 (Q1 2026): FOUNDATION ESTABLISHMENT
■ Establish Regional Task Forces (6 zones)
■ Conduct baseline surveillance assessments
■ Train AMS teams (Kerala model replication)
■ Set up monitoring dashboards
■ Launch public awareness campaigns

PHASE 2 (Q2-Q3 2026): INTERVENTION ROLLOUT
■ Implement ICU AMS protocols (priority)
■ Expand hospital stewardship (secondary)
■ Community education programs (tertiary)
■ Pharmacy regulation strengthening
■ International border surveillance

PHASE 3 (Q4 2026 - Q2 2027): EVALUATION & SCALING
■ Impact assessment (6-month intervals)
■ Best practice documentation
■ Successful model scaling
■ Research collaboration expansion
■ Sustainability planning

PHASE 4 (Q3 2027+): SUSTAINED SURVEILLANCE
■ National benchmarking system
■ Real-time resistance monitoring
■ Policy integration
■ International AMR collaboration
■ Continuous improvement

EXPECTED OUTCOMES:
══════════════════════════════════════════════════════════════════════════════════════
• Reduce ICU antibiotic consumption by 25% within 12 months
• Achieve 70% AWaRe compliance nationally by Q4 2027
• Prevent 50,000 AMR-related infections annually
• Generate 25+ publications on regional AMR interventions
• Establish India as regional AMR leadership example
```

---

```
================================================================================
                 REGIONAL AMR DASHBOARD: TARGETED INTERVENTIONS
================================================================================
                    Evidence-Based Action for India's Federal Structure
================================================================================
